The 8-Aminopurine Hypothesis
The 8-Aminopurine Hypothesis
批准号:
10038684
负责人:
EDWIN Kerry JACKSON
金额:
$50.18万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2024-06-30
关键词:
2-AminopurineAnabolismAnimalsAntihypertensive AgentsBiochemicalBiologicalBlood CirculationBlood PressureBrain InjuriesCardiovascular DiseasesCessation of lifeChemical StructureDahl Hypertensive RatsDeoxycorticosteroneDietDiureticsExcess Dietary SaltExcretory functionFundingGuanineGuanosineHeartHypertensionHypoxanthinesInbred SHR RatsInosineKidneyLeadLongevityMediatingMetabolic syndromeMetabolismModelingOralOral AdministrationOrganPharmacologyPreventionPublishingPurine-Nucleoside PhosphorylaseRattusRenal functionSodium ChlorideStrokeSystemTestingWorkXanthine Oxidaseanalogblood pressure reductiondietary saltexperimental studyhigh salt dietimprovedin vivoinhaled nitric oxideinhibitor/antagonistinterstitialmortalityprematurepreventprotective effectsalt intakesalt sensitive hypertensionsaluretic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have discovered that 8-aminoguanine (8A-Guanine), a naturally-occurring 8-aminopurine, has a unique
pharmacological profile, i.e., it exerts diuretic, natriuretic, glucosuric, antikaluretic and antihypertensive activity.
In addition, 8A-Guanine protects against target-organ damage and increases the lifespan of Dahl SS rats on a
high salt diet, an effect due to prevention of salt-induced strokes. Because 8-aminoguanosine (8A-
Guanosine) is converted to 8A-Guanine in the systemic circulation, this 8-aminopurine has similar effects to
8A-Guanine. The mechanism of action of 8A-Guanine (and 8A-Guanosine via its metabolism to 8A-Guanine) is
mostly via inhibition of purine nucleoside phosphorylase (PNPase). Importantly, in preliminary experiments we
observed that in Dahl SS rats a high salt diet (4%) reduced endogenous renal interstitial levels of 8A-
Guanosine and 8A-Guanine by 85% and 100%, respectively. These preliminary studies suggest that a high
salt intake induces 8-aminopurine deficiency, at least in Dahl SS rats; but this finding must be confirmed in
Dahl SS rats and tested in other models of hypertension. It occurred to us that 8-aminoinosine (8A-Ino) and
8-aminohypoxanthine (8A-HX) have chemical structures very similar to 8A-Guanosine and 8A-Guanine,
respectively, and are analogues of naturally-occurring inosine and hypoxanthine, respectively; therefore we
reasoned that these compounds too may be endogenous 8-aminopurines with beneficial biological activities.
Because no one has ever examined the biological effects of either 8A-Ino or 8A-HX, we conducted preliminary
renal studies with these compounds. These preliminary studies suggest that both 8A-Ino and 8A-HX may have
effects on renal function similar to those of 8A-Guanosine and 8A-Guanine, but may be even more efficacious
in this regard. However, these findings must be confirmed. Also, it is unknown: 1) whether the effects of 8A-Ino
are mediated via its metabolism to 8A-HX; 2) whether 8A-Ino and 8A-HX have antihypertensive and organ-
protective effects; 3) whether 8A-Ino and 8A-HX, like 8A-Guanosine and 8A-Guanine, are naturally-occurring;
and 4) whether their biosynthesis is also suppressed by a high salt diet. Together, our published and
preliminary findings motivate our “8-AMINOPURINE HYPOTHESIS”, which postulates that: 1) 8A-Guanosine,
8A-Guanine, 8A-Ino and 8A-HX comprise a naturally-occurring 8-aminopurine system that is
natriuretic, antihypertensive and organ-protective; 2) 8-aminopurine deficiency contributes to salt-
sensitive hypertension, target-organ damage and mortality; and 3) 8-aminopurine deficiency can be
corrected by oral treatment with 8-aminopurines. Here we propose to further test this hypothesis by: 1)
elucidating the renal effects of 8A-Ino and 8A-HX; 2) determining whether a high salt diet induces a deficiency
in all 4 8-aminopurines; and 3) determining whether 8A-Ino and 8A-HX, like 8A-Guanosine and 8A-Guanine,
have antihypertensive activity and prevent target organ damage. Finally, we will explore whether the
mechanism of action of 8A-Ino and 8A-HX involves not only inhibition of PNPase, but also of xanthine oxidase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Adenosinergic Pathway in Tumor-derived Exosomes
-
批准号:10589774
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2021
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Adenosinergic Pathway in Tumor-derived Exosomes
-
批准号:10374743
-
项目类别:
-
资助金额:$49.11万
-
财政年份:2021
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
2,3 cAMP in Traumatic Brain Injury
-
批准号:9100931
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2014
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Guanosine-Adenosine Mechanism
-
批准号:8499412
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Renal 2',3'-cAMP-Adenosine Pathway
-
批准号:8479345
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Renal 2',3'-cAMP-Adenosine Pathway
-
批准号:9064140
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Renal 2',3'-cAMP-Adenosine Pathway
-
批准号:8282204
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Guanosine-Adenosine Mechanism
-
批准号:8369704
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Guanosine-Adenosine Mechanism
-
批准号:8850478
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The 8-Aminopurine Hypothesis
-
批准号:10650178
-
项目类别:
-
资助金额:$50.96万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Guanosine-Adenosine Mechanism
-
批准号:8669136
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The 8-Aminopurine Hypothesis
-
批准号:10192785
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The 8-Aminopurine Hypothesis
-
批准号:10452626
-
项目类别:
-
资助金额:$50.96万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Renal 2',3'-cAMP-Adenosine Pathway
-
批准号:8853269
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
The Guanosine-Adenosine Mechanism
-
批准号:9265917
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2012
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
Adenosine in Renal Sympathetic Neurotransmission
-
批准号:8322009
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2011
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
Adenosine in Renal Sympathetic Neurotransmission
-
批准号:8897360
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2011
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
Adenosine in Renal Sympathetic Neurotransmission
-
批准号:8727532
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2011
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
Adenosine in Renal Sympathetic Neurotransmission
-
批准号:8151797
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2011
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
Adenosine in Renal Sympathetic Neurotransmission
-
批准号:8541841
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2011
-
负责人:EDWIN Kerry JACKSON
-
依托单位:
海外基金